Agnete W.P. Jensen

Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)

Inna M. Chen, Marco Donia, Christopher A. Chamberlain et al. · European Journal of Cancer · 2022 · 30 citations · Full text

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Arianna Draghi, Mario Presti, Agnete W.P. Jensen et al. · Clinical Cancer Research · 2023 · 16 citations

TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy

Siri Tvingsholm, Marcus Svensson, Vibeke Mindahl Rafa et al. · Journal for ImmunoTherapy of Cancer · 2023 · 15 citations · Full text

Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy

Morten Nielsen, Mario Presti, Zsófia Sztupinszki et al. · Cancer Immunology Research · 2022 · 14 citations · Full text